KRM Ayurveda Limited
KRM Ayurveda Limited (KRMAYURVED): company summary
The company's business is improving, with annual revenue rising 14.9% and net profit surging 300.0%.
KRM Ayurveda Limited (KRMAYURVED) is a micro-cap Healthcare company valued at ₹556 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- KRM Ayurveda Limited last traded at ₹261, modestly down 1.69% on the day.
- Recent developments
- On 2026-08-13, the company released its Monitoring Agency Report for the quarter ended June 30, 2026, indicating ongoing operational monitoring and reporting.
- Financial performance
- The company's business is improving, with annual revenue rising 14.9% and net profit surging 300.0%. The latest quarter saw revenue grow 29.3% compared to the same quarter a year earlier, while net profit jumped 140.0%, driven by a sharp rise in the net profit margin to 15.6% from 4.5%.
- Valuation multiples
- The stock trades at 27.6 times earnings, broadly in line with the Healthcare median of 32.0, 5.20 times book value.
- Things to watch
- The company has not paid dividends despite reporting profits, and debtor days have increased to 81.6 days from 56.5 days. Working capital days have also risen to 280 days from 131 days, indicating potential liquidity challenges.
- Where it stands
- The company has shown strong growth in both revenue and net profit, with the latest quarter reflecting a significant increase in profitability. The most notable movement is the sharp rise in net profit margin, but the company's liquidity metrics have worsened, raising concerns about its operational efficiency.
Summarised by DocStoX's model on 2026-09-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by quality (7.8) and growth (7.4), but held back by valuation (2.6). Quality looks strong at 7.8, but that is offset by valuation at 2.6. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profit compounding 89% a year
- Low leverage — D/E 0.00
- Profitable in all of the last 4 years
- Small ₹556 cr company — thinner liquidity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore KRM Ayurveda Limited’s valuation
Free deep-dive tools · no sign-up
KRM Ayurveda Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare KRM Ayurveda Limited with peers
Related tools & concepts
Value KRM Ayurveda Limited with the ratios and calculators DocStoX uses in its analysis.

